Table 3

Adjusted ORs and 95% CIs for congenital heart anomalies by tertiles of internal THM exposure during the first trimester of pregnancy

THM internal dose tertile limits (µg/d)nFirst month OR* (95% CI)nSecond month OR* (95% CI)nThird month OR* (95% CI)nFirst trimester OR* (95% CI)
TTHM
 0.031–0.040161151181161
 0.040–0.356170.94 (0.47 to 1.88)191.15 (0.58 to 2.28)170.85 (0.43 to 1.67)181.05 (0.53 to 2.07)
 0.356–2.448241.44 (0.76 to 2.74)231.50 (0.78 to 2.91221.17 (0.62 to 2.12)231.38 (0.72 to 2.64)
 p†0.1620.1580.4500.237
 Continuous (1 µg/d)1.96 (1.01 to 3.80)1.90 (0.98 to 3.70)1.72 (0.87 to 3.39)1.88 (0.96 to 3.69)
Chloroform
 0.001–0.026171171161161
 0.026–0.288160.83 (0.41 to 1.65)170.88 (0.45 to 1.75)191.06 (0.54 to 2.08)181.05 (0.53 to 2.08)
 0.288–2.109241.36 (0.72 to 2.56)231.31 (0.70 to 2.49)221.34 (0.69 to 2.57)231.37 (0.72 to 2.63)
 p†0.2250.2830.2790.245
 Continuous (1 µg/d)2.07 (0.96 to 4.46)2.01 (0.92 to 4.38)1.79 (0.80 to 3.99)1.97 (0.90 to 4.35)
BDCM
 0.000–0.013111141161121
 0.013–0.051221.87 (0.90 to 3.88)211.40 (0.71 to 2.78)201.19 (0.61 to 2.31)221.74 (0.85 to 3.54)
 0.051–0.436242.16 (1.05 to 4.46)221.54 (0.78 to 3.04)211.32 (0.68 to 2.56)231.82 (0.89 to 3.69)
 p†0.0240.1440.3090.070
 Continuous (0.1 µg/d)1.77 (1.13 to 2.78)1.69 (1.09 to 2.62)1.59 (1.02 to 2.46)1.70 (1.09 to 2.66)
DBCM
 0.000–0.00220118117118
 0.002–0.006210.96 (0.52 to 1.79)221.17 (0.62 to 2.20)221.24 (0.65 to 2.36)140.73 (0.36 to 1.48)
 0.006–0.093160.71 (0.37 to 1.39)170.87 (0.45 to 1.71)181.00 (0.51 to 1.97)251.35 (0.73 to 2.51)
 p†0.3980.7421.0000.283
 Continuous (0.01 µg/d)1.26 (1.01 to 1.58)1.24 (1.01 to 1.52)1.23 (1.00 to 1.50)1.25 (1.01 to 1.54)
  • *Adjusted for: age, body mass index, chronic disease, alcohol consumption and fetus number.

  • †χ2 for linear trend.

  • BDCM, bromodichloromethane; DBCM, dibromochloromethane; THM, trihalomethane; TTHM, total trihalomethane.